Return On Assets of Inmune Bio, Inc. from 31 Dec 2018 to 31 Dec 2025
- Taxonomy & unit
- ratio: %
- Description
- Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
- Summary
-
Inmune Bio, Inc. quarterly and annual Return On Assets in % history and change rate from 31 Dec 2018 to 31 Dec 2025.
- Inmune Bio, Inc. Return On Assets for the quarter ending 31 Dec 2025 was -130%, a 48% decline year-over-year.
- Inmune Bio, Inc. annual Return On Assets for 2025 was -130%, a 48% decline from 2024.
- Inmune Bio, Inc. annual Return On Assets for 2024 was -88%, a 93% decline from 2023.
- Inmune Bio, Inc. annual Return On Assets for 2023 was -46%, a 45% decline from 2022.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Change (%)
Return On Assets, Annual (%)
Return On Assets, YoY Annual Change (%)
Inmune Bio, Inc. Quarterly Return On Assets (%)
| Period | Value | YoY Chg | Change % | Start Date | End Date |
|---|---|---|---|---|---|
| Q4 2025 | -130% | -42% | -48% | 01 Oct 2025 | 31 Dec 2025 |
| Q3 2025 | -134% | -56% | -70% | 01 Jul 2025 | 30 Sep 2025 |
| Q2 2025 | -132% | -63% | -92% | 01 Apr 2025 | 30 Jun 2025 |
| Q1 2025 | -89% | -31% | -53% | 01 Jan 2025 | 31 Mar 2025 |
| Q4 2024 | -88% | -42% | -93% | 01 Oct 2024 | 31 Dec 2024 |
| Q3 2024 | -79% | -41% | -107% | 01 Jul 2024 | 30 Sep 2024 |
| Q2 2024 | -69% | -35% | -100% | 01 Apr 2024 | 30 Jun 2024 |
| Q1 2024 | -58% | -26% | -77% | 01 Jan 2024 | 31 Mar 2024 |
| Q4 2023 | -46% | -14% | -45% | 01 Oct 2023 | 31 Dec 2023 |
| Q3 2023 | -38% | -4% | -12% | 01 Jul 2023 | 30 Sep 2023 |
| Q2 2023 | -34% | -0.66% | -2% | 01 Apr 2023 | 30 Jun 2023 |
| Q1 2023 | -33% | +3.2% | +8.7% | 01 Jan 2023 | 31 Mar 2023 |
| Q4 2022 | -31% | +4.9% | +14% | 01 Oct 2022 | 31 Dec 2022 |
| Q3 2022 | -34% | +0.7% | +2% | 01 Jul 2022 | 30 Sep 2022 |
| Q2 2022 | -34% | +2.7% | +7.4% | 01 Apr 2022 | 30 Jun 2022 |
| Q1 2022 | -36% | -2.2% | -6.5% | 01 Jan 2022 | 31 Mar 2022 |
| Q4 2021 | -36% | +0.86% | +2.3% | 01 Oct 2021 | 31 Dec 2021 |
| Q3 2021 | -35% | +4.6% | +12% | 01 Jul 2021 | 30 Sep 2021 |
| Q2 2021 | -36% | +3.2% | +8% | 01 Apr 2021 | 30 Jun 2021 |
| Q1 2021 | -34% | -2.8% | -9% | 01 Jan 2021 | 31 Mar 2021 |
| Q4 2020 | -37% | -6.8% | -22% | 01 Oct 2020 | 31 Dec 2020 |
| Q3 2020 | -39% | -8.5% | -28% | 01 Jul 2020 | 30 Sep 2020 |
| Q2 2020 | -40% | -19% | -91% | 01 Apr 2020 | 30 Jun 2020 |
| Q1 2020 | -31% | +18% | +36% | 01 Jan 2020 | 31 Mar 2020 |
| Q4 2019 | -30% | +41% | +58% | 01 Oct 2019 | 31 Dec 2019 |
| Q3 2019 | -31% | 01 Jul 2019 | 30 Sep 2019 | ||
| Q2 2019 | -21% | 01 Apr 2019 | 30 Jun 2019 | ||
| Q1 2019 | -49% | 01 Jan 2019 | 31 Mar 2019 | ||
| Q4 2018 | -72% | 01 Oct 2018 | 31 Dec 2018 |
Inmune Bio, Inc. Annual Return On Assets (%)
| Period | Value | YoY Chg | Change % | Start Date | End Date |
|---|---|---|---|---|---|
| 2025 | -130% | -42% | -48% | 01 Jan 2025 | 31 Dec 2025 |
| 2024 | -88% | -42% | -93% | 01 Jan 2024 | 31 Dec 2024 |
| 2023 | -46% | -14% | -45% | 01 Jan 2023 | 31 Dec 2023 |
| 2022 | -31% | +4.9% | +14% | 01 Jan 2022 | 31 Dec 2022 |
| 2021 | -36% | +0.86% | +2.3% | 01 Jan 2021 | 31 Dec 2021 |
| 2020 | -37% | -6.8% | -22% | 01 Jan 2020 | 31 Dec 2020 |
| 2019 | -30% | 01 Jan 2019 | 31 Dec 2019 |
* An asterisk sign (*) next to the value indicates that the value is likely invalid.